Works cited by this work

151 works

Work: Epigenetic regulation of EZH2 by ncRNAs: mechanisms and oncogenic implications

1. MicroRNA as a Potential Therapeutic Molecule in Cancer

   Joanna Szczepanek, Monika Skorupa, Andrzej Tretyn

   Review article20225 citations

   ABIABI:AkademIndex/openalex/2026.other.281940

2. Unique features of long non-coding RNA biogenesis and function

   Jeffrey J. Quinn, Howard Y. Chang

   Review article20154 citations

   ABIABI:AkademIndex/openalex/2026.other.284717

3. miRNA: A Promising Therapeutic Target in Cancer

   Amrutha Menon, Noraini Abd-Aziz, Kanwal Khalid +2

   Review article20224 citations

   ABIABI:AkademIndex/openalex/2026.other.298171

4. Mechanisms of lncRNA biogenesis as revealed by nascent transcriptomics

   Takayuki Nojima, Nicholas Proudfoot

   Review article20223 citations

   ABIABI:AkademIndex/openalex/2026.other.224133

5. miR‐146a‐5p: Expression, regulation, and functions in cancer

   Joseph R. Iacona, Carol S. Lutz

   Review article20193 citations

   ABIABI:AkademIndex/openalex/2026.other.247348

6. Role of miR-21 as an authentic oncogene in mediating drug resistance in breast cancer

   Shiva Najjary, Reza Mohammadzadeh, Ahad Mokhtarzadeh +3

   Review article20203 citations

   ABIABI:AkademIndex/openalex/2026.other.266395

7. The comprehensive landscape of miR-34a in cancer research

   Sijing Li, Xiaohui Wei, Jinyong He +6

   Review article20213 citations

   ABIABI:AkademIndex/openalex/2026.other.267297

8. RETRACTED ARTICLE: miR-137 mediates the functional link between c-Myc and EZH2 that regulates cisplatin resistance in ovarian cancer

   Jing Sun, Xin Cai, Mingo M. H. Yung +14

   Article20183 citations

   ABIABI:AkademIndex/openalex/2026.other.304871

9. Breast cancer cell–derived microRNA-155 suppresses tumor progression via enhancing immune cell recruitment and antitumor function

   Junfeng Wang, Quanyi Wang, Yinan Guan +10

   Article20222 citations

   ABIABI:AkademIndex/openalex/2026.other.116810

10. Long non-coding RNAs and exosomal lncRNAs: Potential functions in lung cancer progression, drug resistance and tumor microenvironment remodeling

    Maliheh Entezari, Maryam Ghanbarirad, Afshin Taheriazam +11

    Review article20222 citations

    ABIABI:AkademIndex/openalex/2026.other.224134

11. MicroRNA-212 negatively regulates starvation induced autophagy in prostate cancer cells by inhibiting SIRT1 and is a modulator of angiogenesis and cellular senescence

    Malathi Ramalinga, Arpita Roy, Anvesha Srivastava +5

    Article20152 citations

    ABIABI:AkademIndex/openalex/2026.other.226999

12. LncRNA UCA1 promotes cisplatin resistance in gastric cancer via recruiting EZH2 and activating PI3K/AKT pathway

    Qingqiang Dai, Tianqi Zhang, Jiaomeng Pan +1

    Article20202 citations

    ABIABI:AkademIndex/openalex/2026.other.267267

13. EZH2: a novel target for cancer treatment

    Ran Duan, Wenfang Du, Weijian Guo

    Review article20202 citations

    ABIABI:AkademIndex/openalex/2026.other.267273

14. Function of microRNA‑124 in the pathogenesis of cancer (Review)

    Yuchen Liu, Yipin Yang, Xinyi Wang +9

    Review article20232 citations

    ABIABI:AkademIndex/openalex/2026.other.281977

15. The miR-200 Family of microRNAs: Fine Tuners of Epithelial-Mesenchymal Transition and Circulating Cancer Biomarkers

    Ilaria Cavallari, Francesco Ciccarese, Evgeniya Sharova +5

    Review article20212 citations

    ABIABI:AkademIndex/openalex/2026.other.298155

16. Loss of Let-7 Up-Regulates EZH2 in Prostate Cancer Consistent with the Acquisition of Cancer Stem Cell Signatures That Are Attenuated by BR-DIM

    Dejuan Kong, Elisabeth I. Heath, Wei Chen +13

    Article20122 citations

    ABIABI:AkademIndex/openalex/2026.other.304775

17. ALKBH5 promotes invasion and metastasis of gastric cancer by decreasing methylation of the lncRNA NEAT1

    Jun Zhang, Shuai Guo, Haiyan Piao +6

    Article20192 citations

    ABIABI:AkademIndex/openalex/2026.other.304890

18. EZH2 Inhibition and Cisplatin as a Combination Anticancer Therapy: An Overview of Preclinical Studies

    Ivana Samaržija, Marko Tomljanović, Renata Novak Kujundžić +1

    Review article20222 citations

    ABIABI:AkademIndex/openalex/2026.other.304924

19. Ezh2 Inhibition by Tazemetostat: Mechanisms of Action, Safety and Efficacy in Relapsed/refractory Follicular Lymphoma

    Edith Julia, Gilles Salles

    Article20212 citations

    ABIABI:AkademIndex/openalex/2026.other.312730

20. LncRNA H19 promotes lung cancer proliferation and metastasis by inhibiting miR-200a function

    Yi Zhao, Changjiang Feng, Yunjing Li +2

    Article20192 citations

    ABIABI:AkademIndex/openalex/2026.other.418796

21. Decoding hepatocarcinogenesis from a noncoding RNAs perspective

    Mostafa K. Abd El‐Aziz, Alyaa Dawoud, Caroline Joseph Kiriacos +3

    Review article20232 citations

    ABIABI:AkademIndex/openalex/2026.other.418838

22. MiR-26a Inhibits Cell Growth and Tumorigenesis of Nasopharyngeal Carcinoma through Repression of EZH2

    Juan Lü, Ming‐Liang He, Lu Wang +8

    Article20112 citations

    ABIABI:AkademIndex/openalex/2026.other.431242

23. EZH2 couples pancreatic regeneration to neoplastic progression

    Jon Mallen‐St. Clair, Rengin G. Soydaner-Azeloglu, Kyoung Eun Lee +7

    Article20122 citations

    ABIABI:AkademIndex/openalex/2026.other.431258

24. Loss of <i>Ezh2</i> synergizes with <i>JAK2</i> -V617F in initiating myeloproliferative neoplasms and promoting myelofibrosis

    Takafumi Shimizu, Lucia Kubovčáková, Ronny Nienhold +11

    Article20162 citations

    ABIABI:AkademIndex/openalex/2026.other.431267

25. Role of EZH2 in cancer stem cells: from biological insight to a therapeutic target

    Yiping Wen, Jing Cai, Yaya Hou +2

    Review article20172 citations

    ABIABI:AkademIndex/openalex/2026.other.431272